Cristália

Anvisa restrictions on polylaminin use in Brazil

3 clusters · 14 sources · last updated 7 days ago

Latest: Hospital Regional de Barbacena conducts second polylaminin application

Brazil’s National Health Surveillance Agency (Anvisa) has implemented stricter regulations on the compassionate use of polylaminin, an experimental protein derived from human placenta intended for spinal cord injury rege

Brazilian malaria vaccine clinical trials

2 clusters · 8 sources · last updated 26 days ago

Latest: Anvisa authorizes human trials for first Brazilian malaria vivax vaccine

Brazil’s National Health Surveillance Agency (Anvisa) has authorized Phase I human clinical trials for a new vaccine targeting the Plasmodium vivax parasite. Developed by researchers from the Federal University of Minas